A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Rheumatoid arthritis (RA) is strongly associated with the human leukocyte antigen (HLA)-DRB1 locus that possesses the shared susceptibility epitope (SE) and the citrullination of self-antigens. We show how citrullinated aggrecan and vimentin epitopes bind to HLA-DRB1*04:01/04. Citrulline was accommodated within the electropositive P4 pocket of HLA-DRB1*04:01/04, whereas the electronegative P4 pocket of the RA-resistant HLA-DRB1*04:02 allomorph interacted with arginine or citrulline-containing epitopes. Peptide elution studies revealed P4 arginine–containing peptides from HLA-DRB1*04:02, but not from HLA-DRB1*04:01/04. Citrullination altered protease susceptibility of vimentin, thereby generating self-epitopes that are presented to T cells in HLA-DRB1*04:01+ individuals. Using HLA-II tetramers, we observed citrullinated vimentin- and aggrecan-specific CD4+ T cells in the peripheral blood of HLA-DRB1*04:01+ RA-affected and healthy individuals. In RA patients, autoreactive T cell numbers correlated with disease activity and were deficient in regulatory T cells relative to healthy individuals. These findings reshape our understanding of the association between citrullination, the HLA-DRB1 locus, and T cell autoreactivity in RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MEME SUITE: tools for motif discovery and searching
Bailey, T. L., Boden, M., Buske, F. A., Frith, M., Grant, C. E., Clementi, L., Ren, J., Li, W. W., & Noble, W. S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp335 · Cited by 10,648
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27584 · Cited by 9,619
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H., Deyo, R. A., Gabriel, S., Hirsch, R., Hochberg, M. C., Hunder, G. G., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23176 · Cited by 5,499
Gregersen, P. K., Silver, J., & Winchester, R. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301102 · Cited by 2,599 · cited 3×
“Alleles having this shared conserved region of the DR 70–74 region are termed to have a shared susceptibility epitope (SE; Gregersen et al., 1987) and include the commonly occurring HLA DRB1*04:01, *04:04, and *01:01 molecules.”
BackgroundInfluentialMiyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291 · cited 2×
“…and activated CD45RAFoxp3+CD25hi suppressive populations (regulatory T [T reg] cells), and Foxp3loCD45RA and Foxp3-CD45RA+ and CD45RA nonsuppressive populations, which each have potential for proinflammatory cytokine production upon stimulation ex vivo (Miyara et al., 2009, 2011).”
BackgroundEstimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
Helmick, C. G., Felson, D. T., Lawrence, R. C., Gabriel, S., Hirsch, R., Kwoh, C. K., Liang, M. H., Kremers, H. M., Mayes, M. D., Merkel, P. A., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23177 · Cited by 2,058
Raychaudhuri, S., Sandor, C., Stahl, E. A., Freudenberg, J., Lee, H.-S., Jia, X., Alfredsson, L., Padyukov, L., Klareskog, L., Worthington, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.1076 · Cited by 946 · cited 4×
“1.6 1.9 2.1 1.3 1 1.8 1.8 aRp.i.m = hkl [1/(N 1)]1/2 i | Ihkl, i <Ihkl> | / hkl <Ihkl> bRfactor = ( | |Fo| |Fc|”
BackgroundInfluentialKlareskog, L., Catrina, A. I., & Paget, S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60008-8 · Cited by 787
A time- and cost-efficient system for high-level protein production in mammalian cells
Aricescu, A. R., Lu, W., & Jones, E. Y. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906029799 · Cited by 762 · cited 2×
“The extracellular domains of the HLA-DR4 (DRA*01:01/DRB1*04:01, *04:02, and *04:04) and chains were cloned into the pHLsec (Aricescu et al., 2006) vector for expression in HEK 293S (GnTI) cells (Reeves et al., 2002).”
MethodImproved visualization of protein consensus sequences by iceLogo
Colaert, N., Helsens, K., Martens, L., Vandekerckhove, J., & Gevaert, K. (2009) · Nature Methods · doi:10.1038/nmeth1109-786 · Cited by 741
Cited by
Items 101–200 of 505
Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens
Koning, F., Thomas, R., Rossjohn, J., & Toes, R. E. M. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.59 · Cited by 68
Self-citationGenetic basis of rheumatoid arthritis: A current review
Kochi, Y., Suzuki, A., & Yamamoto, K. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.085 · Cited by 67
Recent Advances in Defining the Genetic Basis of Rheumatoid Arthritis
Terao, C., Raychaudhuri, S., & Gregersen, P. K. (2016) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090314-045919 · Cited by 67
Rappazzo, C. G., Huisman, B. D., & Birnbaum, M. E. (2020) · Nature Communications · doi:10.1038/s41467-020-18204-2 · Cited by 67
Sonigra, A., Nel, H. J., Wehr, P., Ramnoruth, N., Patel, S. P., van Schie, K. A., Bladen, M. W., Mehdi, A. M., Tesiram, J., Talekar, M., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160964 · Cited by 67
“To assess T cell immunomodulation, we evaluated total CD4+ and CD8+ T cells, antigen-specific CD4+ T cells responsive to CII administered in DEN-181, and bystander CD4+ T cells recognizing Cit64vimentin59-71 (Cit-Vim), a well-described autoantigenic epitope restricted by HLADRB1*04:01 and *01:01 (23, 29, 30).”
BackgroundSelf-citationT cell receptor recognition of hybrid insulin peptides bound to HLA-DQ8
Tran, M. T., Faridi, P., Lim, J. J., Ting, Y. T., Onwukwe, G. U., Bhattacharjee, P., Jones, C. M., Tresoldi, E., Cameron, F. J., Gruta, N. L. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25404-x · Cited by 66
Self-citationMastrángelo, A., Colasanti, T., Barbati, C., Pecani, A., Sabatinelli, D., Pendolino, M., Truglia, S., Massaro, L., Mancini, R., Miranda, F., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/712490 · Cited by 64
“Two questions arising from these data still remain partially unsolved: why do RA patient antibodies recognize as “non-self ” the citrullinated proteins? And how citrullinated antigens are produced? The first question found a partial answer in the strong association between ACPA-positive RA and specific HLA polymorphis…”
BackgroundNagafuchi, Y., Shoda, H., Sumitomo, S., Nakachi, S., Kato, R., Tsuchida, Y., Tsuchiya, H., Sakurai, K., Hanata, N., Tateishi, S., et al. (2016) · Scientific Reports · doi:10.1038/srep29338 · Cited by 64
“These findings strongly suggest that acquired immunity against autoantigens promotes local inflammation in the synovium, such as macrophage activation and inflammatory cytokine production, including TNF-α and IL-6.”
Memory T cells specific to citrullinated α-enolase are enriched in the rheumatic joint
Pieper, J., Dubnovitsky, A. P., Gerstner, C., James, E. A., Rieck, M., Kozhukh, G., Tandre, K., Pellegrino, S., Gebe, J. A., Rönnblom, L., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.04.004 · Cited by 64
Genetics of rheumatoid arthritis in Asia—present and future
Yamamoto, K., Okada, Y., Suzuki, A., & Kochi, Y. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.7 · Cited by 63
Walsh, A. M., Wechalekar, M. D., Guo, Y., Yin, X., Weedon, H., Proudman, S., Smith, M., & Nagpal, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183928 · Cited by 63
Autoantigens as Partners in Initiation and Propagation of Autoimmune Rheumatic Diseases
Rosen, A., & Casciola-Rosen, L. A. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112205 · Cited by 62
Mukherjee, A., Jantsch, V., Khan, R., HARTUNG, W. M., Fischer, R., Jantsch, J., Ehrenstein, B. P., Konig, M. F., & Andrade, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02352 · Cited by 62
“These residues are located within the antigen-binding groove of the HLA class II molecule (10), and may facilitate presentation of citrullinated self-peptides (12).”
BackgroundScally, S. W., Law, S. C., Ting, Y. T., van Heemst, J., Sokolove, J. B., Deutsch, A. J., Clemens, E. B., Moustakas, A. K., Papadopoulos, G. K., van der Woude, D., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211300 · Cited by 61
Self-citationA Roadmap Toward the Definition of Actionable Tumor-Specific Antigens
Minati, R., Perreault, C., & Thibault, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583287 · Cited by 61
“Although the presentation of citrullinated MAPs on MHC I molecules has never been demonstrated, citrullination was shown to increase peptides binding affinity for HLA‐DRB1 (a MHC class II allele) (164, 165) which could then be recognized by both mice and human repertoires of “cytotoxic” CD4 T cells (166–168).”
BackgroundThe Cellular Redox Environment Alters Antigen Presentation
Trujillo, J. A., Croft, N. P., Dudek, N. L., Channappanavar, R., Theodossis, A., Webb, A. I., Dunstone, M. A., Illing, P. T., Butler, N. S., Fett, C., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.573402 · Cited by 61
Self-citationAutophagy pathways in autoimmune diseases
Keller, C. W., Adamopoulos, I. E., & Lünemann, J. D. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103030 · Cited by 59
“For example, citrullinated vimentin exhibits modified proteolytic cleavage, which leads to a much stronger propensity to bind to HLA-DRB1*04:01 (a known risk allele for RA) than vimentin, which harbors the corresponding arginine [142].”
BackgroundApplying MAPPs Assays to Assess Drug Immunogenicity
Karle, A. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00698 · Cited by 59
A molecular basis of human T cell receptor autoreactivity toward self-phospholipids
Shahine, A., Rhijn, I. V., Cheng, T., Iwany, S. K., Gras, S., Moody, D. B., & Rossjohn, J. (2017) · Science Immunology · doi:10.1126/sciimmunol.aao1384 · Cited by 58
Self-citationThe Immunoproteasome: An Emerging Target in Cancer and Autoimmune and Neurological Disorders
Zerfas, B. L., Maresh, M. E., & Trader, D. J. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01226 · Cited by 57
Sugawara, E., Kato, M., Kudo, Y., Lee, W. S., Hisada, R., Fujieda, Y., Oku, K., Bohgaki, T., Amengual, O., Yasuda, S., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1664144 · Cited by 56
“C-VIM is identified as a T cell epitope in SE containing RA-susceptible HLA-DRB alleles [6,27,28].”
BackgroundT-cell responses to hybrid insulin peptides prior to type 1 diabetes development
Mitchell, A. M., Alkanani, A. K., McDaniel, K. A., Pyle, L. L., Waugh, K., Steck, A. K., Nakayama, M., Yu, L., Gottlieb, P. A., Rewers, M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019129118 · Cited by 55
“of autoimmune diseases, including citrullinated peptides in rheumatoid arthritis (11), deamidated peptides in celiac disease (7–10), and HIPs in T1D (12, 13, 28, 29).”
BackgroundAntibody Cross-Reactivity in Auto-Immune Diseases
Trier, N. H., & Houen, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713609 · Cited by 56
Interleukin-9 and T helper type 9 cells in rheumatic diseases
Ciccia, F., Guggino, G., Ferrante, A., Cipriani, P., Giacomelli, R., & Triolo, G. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12807 · Cited by 55
Mitchell, T., Moots, R. J., & Wright, H. L. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12970 · Cited by 55
A roadmap of the generation of neoantigens as targets of the immune system in type 1 diabetes
Roep, B. O., Kracht, M. J. L., van Lummel, M., & Zaldumbide, A. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.09.007 · Cited by 55
Understanding the complexity and malleability of T‐cell recognition
Miles, J. J., McCluskey, J., Rossjohn, J., & Gras, S. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2014.112 · Cited by 54
Self-citationHLA class II and rheumatoid arthritis: the bumpy road of revelation
Kampstra, A. S. B., & Toes, R. E. M. (2017) · Immunogenetics · doi:10.1007/s00251-017-0987-5 · Cited by 54
Self-citationTutorial: a statistical genetics guide to identifying HLA alleles driving complex disease
Sakaue, S., Gurajala, S., Curtis, M. L., Luo, Y., Choi, W., Ishigaki, K., Kang, J. B., Rumker, L., Deutsch, A. J., Schönherr, S., et al. (2023) · Nature Protocols · doi:10.1038/s41596-023-00853-4 · Cited by 52
Citrullination only infrequently impacts peptide binding to HLA class II MHC
Sidney, J., Bécart, S., Zhou, M., Duffy, K. E., Lindvall, M., Moore, E. C., Moore, E. L., Rao, T. S., Rao, N. L., Nielsen, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177140 · Cited by 53
Pan-Immune-Inflammation Index as a Biomarker for Rheumatoid Arthritis Progression and Diagnosis
Tutan, D., & DOĞAN, A. G. (2023) · Cureus · doi:10.7759/cureus.46609 · Cited by 52
“Naïve CD4 T cells undergo differentiation into pro-inflammatory helper T cells, characterized by an enhanced capacity to infiltrate tissues and incite inflammation via immune cell-mediated cytotoxicity [8,9].”
Rigby, W. F. C., Buckner, J. H., Bridges, S. L., Nys, M., Gao, S., Polinsky, M. S., Ray, N., & Bykerk, V. P. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02607-7 · Cited by 52
Chemin, K., Pollastro, S., James, E. A., Ge, C., Albrecht, I., Herrath, J., Gerstner, C., Tandre, K., Rizzi, T. S., Rönnblom, L., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39553 · Cited by 52
“Thus far, citrulline residues have been shown to profoundly influence binding in positions 4, 7, and 9 of the HLA–DR– binding motif (23,24).”
BackgroundInfluentialMobbs, J. I., Illing, P. T., Dudek, N. L., Brööks, A. G., Baker, D. G., Purcell, A. W., Rossjohn, J., & Vivian, J. P. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.806976 · Cited by 51
“For example, the presentation of citrullinated self-epitopes by HLA-DRB1*04:01/04 in rheumatoid arthritis (13, 14) and the presentation of deamidated peptides derived from dietary gluten by HLA-DQ8 and HLA-DQ2 in celiac disease (15–17).”
BackgroundSelf-citationMisasi, R., Longo, A., Recalchi, S., Caissutti, D., Riitano, G., Manganelli, V., Garofalo, T., Sorice, M., & Capozzi, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218411 · Cited by 51
“In particular, citrullination, carbamylation and acetylation, as well as the binding to phospholipids are involved in conformation changing of vimentin, promoting the exposure of neoepitopes to the immune system [79].”
BackgroundBreach of autoreactive B cell tolerance by post-translationally modified proteins
Dekkers, J., Verheul, M. K., Stoop, J. N., Liu, B., Ioan‐Facsinay, A., van Veelen, P. A., de Ru, A. H., Janssen, G. M. C., Hegen, M., Rapecki, S., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210772 · Cited by 51
Self-citationThe shared susceptibility epitope of HLA-DR4 binds citrullinated self-antigens and the TCR
Lim, J. J., Jones, C. M., Loh, T. J., Ting, Y. T., Zareie, P., Loh, K. L., Felix, N. J., Suri, A., McKinnon, M., Stevenaert, F., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abe0896 · Cited by 50
Self-citationCytokines pre-determined by genetic factors are involved in pathogenesis of Rheumatoid arthritis
Taneja, V. (2014) · Cytokine · doi:10.1016/j.cyto.2014.11.028 · Cited by 48
“Using DR4 tetramers, it was shown that while both RA patients and healthy individuals harbor DR4 positive T cells although T regulatory cells are diminished in patients [27].”
BackgroundResultJadeja, S. D., & Tobin, D. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.890027 · Cited by 47
Infections as a cause of autoimmune rheumatic diseases
Sakkas, L. I., & Bogdanos, D. P. (2016) · Autoimmunity Highlights · doi:10.1007/s13317-016-0086-x · Cited by 46
“Indeed, HLADRB1*SE alleles bind to citrullinated peptides in RA, as citrulline but not arginine was eluted from HLADRB1*04:01/04(SE) alleles [28].”
BackgroundAn immunogenetic basis for lung cancer risk
Krishna, C., Tervi, A. M., Saffern, M., Wilson, E. A., Yoo, S., Mars, N., Roudko, V., Cho, B. A., Jones, S. E., Vaninov, N., et al. (2024) · Science · doi:10.1126/science.adi3808 · Cited by 48
“Several of the significant positions have been previously implicated in other diseases — e.g., P70 in DRB1 , previously associated with rheumatoidarthritis( 70 ) — inadditiontosmoking and Parkinson ’ s disease ( 71 ).”
BackgroundProtective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease
Tatari-Calderone, Z., Gordish‐Dressman, H., Fasano, R. M., Riggs, M., Fortier, C., Campbell, A., Charron, D. J., Gordeuk, V. R., Luban, N. L. C., Vukmanović, S., et al. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.10.010 · Cited by 45
“The susceptibility status conferred by the HLA-DRB1*04 allele might be explained by the previously demonstrated efficient capacity of this allelic variant in presenting antigenic peptides to CD4+ T-cells with consequent activation and polarization of CD4 T-cells [32].”
BackgroundA possible role for autoimmunity through molecular mimicry in alphavirus mediated arthritis
Venigalla, S. S. K., Premakumar, S., & Vani, J. (2020) · Scientific Reports · doi:10.1038/s41598-019-55730-6 · Cited by 45
Genetics of rheumatoid arthritis
Sharma, S. D., Leung, S. H., & Viatte, S. (2024) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2024.101968 · Cited by 44
Glymphatics and meningeal lymphatics unlock the brain-immune code
Kim, M. W., & Kipnis, J. (2025) · Immunity · doi:10.1016/j.immuni.2025.03.006 · Cited by 44
Crystallographic Studies of Intermediate Filament Proteins
Guzenko, D., Chernyatina, A. A., & Strelkov, S. V. (2017) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-319-49674-0_6 · Cited by 44
Mei, S., Ayala, R., Ramarathinam, S. H., Illing, P. T., Faridi, P., Song, J., Purcell, A. W., & Croft, N. P. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001846 · Cited by 44
Self-citationProinsulin-Reactive CD4 T Cells in the Islets of Type 1 Diabetes Organ Donors
Landry, L. G., Anderson, A. M., Russ, H. A., Yu, L., Kent, S. C., Atkinson, M. A., Mathews, C. E., Michels, A. W., & Nakayama, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.622647 · Cited by 44
Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis
McLaughlin, R. J., Spindler, M. P., van Lummel, M., & Roep, B. O. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0752-4 · Cited by 44
Rheumatoid arthritis is a preventable disease: 11 ways to reduce your patients' risk
Smith, L., Mehdi, A. M., MARCH, L. M., Tooth, L. R., Mishra, G. D., & Thomas, R. (2021) · Internal Medicine Journal · doi:10.1111/imj.15537 · Cited by 43
Self-citationMHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange
Abualrous, E. T., Stolzenberg, S., Sticht, J., Wieczorek, M., Roske, Y., Günther, M., Dähn, S., Boesen, B. B., Calvo, M. M., Biese, C., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01316-3 · Cited by 43
Scholz, E., Marcilla, M., Daura, X., Arribas-Layton, D., James, E. A., & Álvarez, I. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00984 · Cited by 42
“The binding motifs of these allotypes have been described using transfectants where the DRB4 gene was not expressed (40).”
BackgroundAuger, I., Balandraud, N., Massy, E., Hemon, M. F., Peen, E., Arnoux, F., Mariot, C., Martin, M., Lafforgue, P., Busnel, J., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41189 · Cited by 43
“(10) and later by binding and structural studies performed with a few highly selected peptides (20,21).”
BackgroundSatała, D., Gonzalez‐Gonzalez, M., Smolarz, M., Surowiec, M., Kulig, K., Wronowska, E., Zawrotniak, M., Kozik, A., Rąpała‐Kozik, M., & Karkowska‐Kuleta, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.765942 · Cited by 44
“The modification of arginine to citrulline might result in the altered presentation of the modified peptides to CD4+ T cells, as these two amino acids differ in the affinity to the binding pockets of HLA-DR (human leukocyte antigen–DR isotype) proteins in favor of the latter (Scally et al., 2013).”
BackgroundGuo, J., Zhang, T., Cao, H., Li, X., Liang, H., Liu, M., Zou, Y., Zhang, Y., Wang, Y., Sun, X., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214725 · Cited by 42
Bawadekar, M., Gendron‐Fitzpatrick, A., Rebernick, R. J., Shim, D., WARNER, T. F. C. S., Nicholas, A. P., Lundblad, L. K. A., Thompson, P. R., & Shelef, M. A. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1068-0 · Cited by 42
“tides [34].”
HLA ‐B*40:02 and DRB 1*04:03 are risk factors for oxcarbazepine‐induced maculopapular eruption
Moon, J., Kim, T., Lim, J., Sunwoo, J., Byun, J., Lee, S., Jung, K., Park, K., Jung, K., Jeon, D., et al. (2016) · Epilepsia · doi:10.1111/epi.13566 · Cited by 41
Roudier, J., Balandraud, N., & Auger, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.930112 · Cited by 41
“They showed direct binding of Vim R70Cit to HLA- DRB1*04:01, *04:04 and HLADRB1*04:02, the latter unexpected, because HLA-DRB1*04:02 does not contain the shared epitope and is not associated with RA (7).”
BackgroundInfectomics and autoinfectomics: a tool to study infectious-induced autoimmunity
Bogdanos, D. P., Smyk, D. S., Rigopoulou, E. I., Sakkas, L. I., & Shoenfeld, Y. (2015) · Lupus · doi:10.1177/0961203314559088 · Cited by 40
Rheumatoid arthritis: ‘melting pot’ of T helper subsets
Vyas, S., Hansda, A. K., & Goswami, R. (2019) · International Reviews of Immunology · doi:10.1080/08830185.2019.1621865 · Cited by 40
“The increased autoreactive T cell number correlated with the disease activity [53].”
BackgroundTowards prevention of autoimmune diseases: The example of rheumatoid arthritis
Hensvold, A. H., & Klareskog, L. (2021) · European Journal of Immunology · doi:10.1002/eji.202048952 · Cited by 38
Molecules in medicine mini review: the αβ T cell receptor
Clambey, E. T., Davenport, B., Kappler, J. W., Marrack, P., & Homann, D. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1145-2 · Cited by 37
“TCR reactivity to modified peptides is thought to underlie certain types of immune pathologies including rheumatoid arthritis, where RA patients have an anticitrullinated peptide response [21], and chronic beryllium disease, where patients have an inappropriate reactivity to the metal ion beryllium [22].”
Kim, J., Park, J., Yim, H. W., Lee, J. J., Kwok, S., Ju, J. H., Kim, W., & Park, S. (2018) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2018.093 · Cited by 37
“Smoking plus human leukocyte antigen (HLA)-DRB1 shared epitope alleles are associated with citrullination of peptides, which triggers anti-citrullinated peptide antibody (ACPA) responses in RA [9,10].”
BackgroundStefano, L. D., D’Onofrio, B., Manzo, A., Montecucco, C., & Bugatti, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212386 · Cited by 36
“The presence of basic aminoacids, such as histidine, at position 13 indeed strongly confers risk of ACPA production [24], whilst not charged or negatively charged aminoacids have been reported to be associated with autoantibody-negative juvenile and adult polyarthritis [25].”
BackgroundDisease mechanisms in preclinical rheumatoid arthritis: A narrative review
Romão, V. C., & Fonseca, J. E. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.689711 · Cited by 36
Kampstra, A. S. B., van Heemst, J., Moustakas, A. K., Papadopoulos, G. K., Huizinga, T. W. J., & Toes, R. E. M. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1153-4 · Cited by 36
“Discussion Over a decade ago, it was first demonstrated that arginine-to-citrulline conversion enhances the affinity of peptides for HLA-DRB1-SE alleles [7, 8].”
BackgroundSelf-citationAntigen discovery for the development of cancer immunotherapy
Ahn, R., Cui, Y., & White, F. M. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101733 · Cited by 35
Liang, M., Matteson, E. L., Abril, A., & Distler, J. H. W. (2022) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x221074457 · Cited by 34
Hair Follicle Melanocytes Initiate Autoimmunity in Alopecia Areata: a Trigger Point
Xie, B., Sun, J., & Song, X. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-022-08954-w · Cited by 34
Anti-citrullinated protein antibodies as biomarkers in rheumatoid arthritis
Trier, N. H., & Houen, G. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2247986 · Cited by 34
“Citrulline-containing peptides have also been reported to bind well to some MHC II forms [199–201].”
BackgroundHLA and rheumatoid arthritis: How do they connect?
van Heemst, J., van der Woude, D., Huizinga, T. W. J., & Toes, R. E. M. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.907097 · Cited by 34
Self-citationDarrah, E., Kim, A., Zhang, X., Boronina, T. N., Cole, R. N., Fava, A., Giles, J. T., Bingham, C. O., Chalmers, M. J., Griffin, P. R., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00617 · Cited by 34
“were identified: MAQ(1-17), ASP(44-61), LTM(78-93), ISY(94-105), IGY(354-368), RGP(394-”
InfluentialDamm‐Ganamet, K. L., Arora, N. R., Bécart, S., Edwards, J. P., Lebsack, A. D., McAllister, H., Nelen, M. I., Rao, N. L., Westover, L., Wiener, J. J. M., et al. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00941 · Cited by 34
Bentzen, A. K., & Hadrup, S. R. (2019) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2019.06.003 · Cited by 33
Darrah, E., & Andrade, F. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38970 · Cited by 33
“In addition, there is evidence to indicate that ACPAs may have effector functions, including stimulating Toll-like receptor 4 and activating complement (36,37), among other functions (25,38,39).”
BackgroundThe Badgers of Wytham Woods: A Model for Behaviour, Ecology, and Evolution
Macdonald, D. W., & Newman, C. (2022) · doi:10.1093/oso/9780192845368.001.0001 · Cited by 32
Review: Neutrophils as Invigorated Targets in Rheumatic Diseases
Grayson, P. C., Schauer, C., i, M. H., & Kaplan, M. J. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39745 · Cited by 32
“Responses to citrullinated autoantigens are considered to be key steps in the pathogenesis of RA (45).”
BackgroundA Systems Approach to Understand Antigen Presentation and the Immune Response
Dudek, N. L., Croft, N. P., Schittenhelm, R. B., Ramarathinam, S. H., & Purcell, A. W. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3341-9_14 · Cited by 32
Self-citationSynovial Tissue Insights into Heterogeneity of Rheumatoid Arthritis
Jonsson, A. H. (2023) · Current Rheumatology Reports · doi:10.1007/s11926-023-01129-2 · Cited by 31
“…epitope appear to be particularly suited to present citrullinated peptides to CD4 T cells, providing a potential mechanism for the development of anti-citrullinated protein antibodies (ACPAs, also referred to as anti-cyclic citrullinated peptide (anti-CCP) antibodies) in seropositive RA [19, 20].”
Travers, T. S., Harlow, L. A., Rosas, I. O., Gochuico, B. R., Mikuls, T. R., Bhattacharya, S. K., Camacho, C. J., & Ascherman, D. P. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600162 · Cited by 31
Bidkar, M., Vassallo, R., Luckey, D. H., Smart, M. K., Mouapi, K., & Taneja, V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162341 · Cited by 31
“Our observations are consistent with prior published data demonstrating the presence of Cit-Vim reactive CD4+ T-cells in both, 0401+ RA-patients as well as healthy controls [22, 23], suggesting that the presence of antigen-specific T-cells is insufficient to drive RA development.”
ResultSnir, O., Gómez-Cabrero, D., Montes, A., Pérez-Pampín, E. M., Gómez-Reino, J. J., Seddighzadeh, M., Klich, K., Israelsson, L., Ding, B., Catrina, A. I., et al. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0414-3 · Cited by 31
The role of anticitrullinated protein antibodies in the early stages of rheumatoid arthritis
Dekkers, J., Toes, R. E. M., Huizinga, T. W. J., & van der Woude, D. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000277 · Cited by 31
Self-citationACPA mediates the interplay between innate and adaptive immunity in rheumatoid arthritis
Dong, X., Zheng, Z., Zhai, Y., Zheng, Y., Ding, J., Jiang, J., & Zhu, P. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.02.014 · Cited by 31
Loh, T. J., Lim, J. J., Jones, C. M., Dao, H. T., Tran, M. T., Baker, D. G., Gruta, N. L. L., Reid, H. H., & Rossjohn, J. (2024) · Nature Communications · doi:10.1038/s41467-024-50511-w · Cited by 30
“Negatively charged and polar/neutral residues are favoured to occupy P4 whereas positively charged residues are disfavoured due to charge repulsion 4 .”
Self-citationT Cell Dysregulation in Rheumatoid Arthritis: from Genetic Susceptibility to Established Disease
Chin, A., Small, A., Wong, S. W., & Wechalekar, M. D. (2025) · Current Rheumatology Reports · doi:10.1007/s11926-025-01180-1 · Cited by 30
Khalifa, O., Balandraud, N., Lambert, N. C., Auger, I., Roudier, J., Sénéćhal, A., Geneviève, D., Picard, C., Lefranc, G., Touitou, I., et al. (2017) · Journal of Immunology Research · doi:10.1155/2017/4915950 · Cited by 30
Ramarathinam, S. H., Gras, S., Alcântara, S., Yeung, A. W. S., Mifsud, N. A., Sonza, S., Illing, P. T., Glaros, E. N., Thomas, S. R., Kent, S. J., et al. (2018) · PROTEOMICS · doi:10.1002/pmic.201700253 · Cited by 30
Self-citationInterleukin-6 (IL-6) Receptor Antagonist Protects Against Rheumatoid Arthritis
Li, S., Wu, Z., Li, L., & Liu, X. (2016) · Medical Science Monitor · doi:10.12659/msm.896355 · Cited by 30
Too, C. L., Murad, S., Erlandsson, M. C., Heselynn, H., Sulaiman, W., Dhaliwal, J. S., & Bokarewa, M. I. (2015) · Medicine · doi:10.1097/md.0000000000000468 · Cited by 29
Harbige, J., Eichmann, M., & Peakman, M. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.08.001 · Cited by 28
Houtman, M., Dzebisashvili, A., Hesselberg, E., Dubnovitsky, A. P., Kozhukh, G., Rönnblom, L., Klareskog, L., Malmström, V., & Padyukov, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.707217 · Cited by 27
van Steenbergen, H. W., Raychaudhuri, S., Rodríguez‐Rodríguez, L., Rantapää‐Dahlqvist, S., Berglin, E., Toes, R. E. M., Huizinga, T. W. J., Fernández‐Gutiérrez, B., Gregersen, P. K., & Mil, A. H. M. V. D. H. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39018 · Cited by 27
“Further 3-dimensional modeling studies or binding assays, such as described previously by Scally et al (27) are needed to determine whether the present findings result in novel insights in the consequences of the HLA–DRB1 motif on antigen presentation and its function as an immune response gene.”
MethodSelf-citationA microfluidic-SERSplatform for isolation and immuno-phenotyping of antigen specific T-cells
Dey, S., Vaidyanathan, R., Khondakar, K. R., Wang, J., Wang, Y., Nel, H. J., Law, S. C., Tyler, J., Rossjohn, J., Reid, H. H., et al. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.12.099 · Cited by 26
“Hemagglutinin306-318 (HA) specific- CD4 T-cell clones were generated as described previously [33].”
Self-citationPre-fractionation Extends but also Creates a Bias in the Detectable HLA Class Ι Ligandome
Demmers, L. C., Heck, A. J. R., & Wu, W. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00821 · Cited by 26
TCR-like antibodies targeting autoantigen-mhc complexes: a mini-review
Li, Y., Jiang, W., & Mellins, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.968432 · Cited by 26
Expansion of CD8+ cells in autoimmune hemolytic anemia
Smirnova, S., Sidorova, Y. V., Tsvetaeva, N. V., Nikulina, O. F., Вениаминовна, Б. Б., Nikulina, E., Kulikov, S. M., & Sudarikov, A. B. (2016) · Autoimmunity · doi:10.3109/08916934.2016.1138219 · Cited by 26
HLA Amino Acid Polymorphisms and Kidney Allograft Survival
Kamoun, M., McCullough, K. P., Maiers, M. J., Fernández-Viña, M., Li, H., Teal, V. L., Leichtman, A. B., & Merion, R. M. (2017) · Transplantation · doi:10.1097/tp.0000000000001670 · Cited by 26
Laha, A., Nasra, S., Bhatia, D. D., & Kumar, A. (2024) · Nanoscale · doi:10.1039/d4nr02182g · Cited by 25
Abacar, K., Macleod, T., Direskeneli, H., & McGonagle, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1439371 · Cited by 25
Metadata
- Authors
- Scally, S. W., Petersen, J., Law, S. C., Dudek, N. L., Nel, H. J., Loh, K. L., Wijeyewickrema, L. C., Eckle, S. B. G., van Heemst, J., Pike, R. N., McCluskey, J., Toes, R. E., La Gruta, N. L., Purcell, A. W., Reid, H. H., Thomas, R., & Rossjohn, J.
- Affiliations
- Monash University (AU)
- Translational Research Institute (AU)
- The University of Melbourne (AU)
- Department of Rheumatology, Leiden University Medical Center, 2300 RC Leiden, Netherlands 4
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria 3010, Australia 3
- Corresponding author
- Purcell, Anthony W.
- Reid, Hugh H.
- Thomas, Ranjeny
- Rossjohn, Jamie
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2013-11-04
- Volume
- 210
- Issue
- 12
- Pages
- 2569-2582
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3832918
- OpenAlex
- W2146707828
- Cited by
- 429
- References
- 59
- Citations by year
- 2026: 22 · 2025: 22 · 2024: 27 · 2023: 42 · 2022: 25 · 2021: 31 · 2020: 33 · 2019: 41 · 2018: 36 · 2017: 41 · 2016: 48 · 2015: 35 · 2014: 25 · 2013: 1
- FWCI
- 29.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-sa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Funders
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- rheumatoid arthritis, HLA-DRB1, citrullination, citrullinated vimentin, HLA-DRB1*0401, peptide binding, autoreactive T cells, CD4+ T cells, regulatory T cells, disease activity, autoantigens
- MeSH terms
- Amino Acid Sequence, Animals, Epitopes, Arthritis, Rheumatoid, Autoantigens, Citrulline, Humans, Mice, Transgenic, Models, Molecular, Molecular Sequence Data, Polymorphism, Genetic, Vimentin, CD4-Positive T-Lymphocytes, HLA-DR4 Antigen, Antigen Presentation, Mice, Aggrecans, Genetic Association Studies, HLA-DR beta-Chains, HLA-DRB1 Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.